These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20879105)

  • 21. [Effects of nootropic agents on visual functions and lacrimal antioxidative activity in patients with primary open-angle glaucoma].
    Davydova NG; Kuznetsova TP; Borisova SA; Abdulkadyrova MZh
    Vestn Oftalmol; 2006; 122(6):42-5. PubMed ID: 17217203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Augmented antipsychotic therapy with pantogam active in patients with schizophrenia].
    Medvedev VE; Frolova VI; Gushanskaya EV; Ter-Israelyan AU
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):28-34. PubMed ID: 26356612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Possible applications of rac-hopantenic acid in the treatment of cognitive, anxiety and depressive disorders in patients with essential arterial hypertension].
    Ostroumova OD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):115-121. PubMed ID: 30499507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Asthenic disorders in children].
    Chutko LS; Surushkina SIu; Nikishena IS; Iakovenko EA; Anisimova TI; Kuzovenkova MP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 1):26-9. PubMed ID: 21183919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of cognitive and non-cognitive symptoms in cerebrovascular disease].
    Litvinenko IV; Naumov KM; Odinak MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):35-40. PubMed ID: 24874315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogenetic therapy of trigeminal neuralgia].
    Karlov VA; Megdiatov RS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(4):51-4. PubMed ID: 3414249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative investigation of calcium ketopantoylaminobutyrate and pantogam: tranquilizer activity].
    Karaev AL; Kozlova GS; Smirnova TN; Gunar VI
    Eksp Klin Farmakol; 2004; 67(6):20-2. PubMed ID: 15707008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alcoholic intoxication and the gamma-aminobutyric acid system of the brain in exposure to pantogam and fenibut].
    Sytinskiĭ IA; Kopelevich VM; Nikitina ZS; Polevoĭ LG
    Farmakol Toksikol; 1986; 49(2):79-82. PubMed ID: 3709782
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical and neurophysiological objectification and evaluation of treatment efficacy in children with perinatal hypoxic-ischemic injury of the CNS].
    Grebennikova OV; Zavadenko AN; Rogatkin SO; Medvedev MI; Degtiareva MG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):63-7. PubMed ID: 24874320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of omaron in patients with post-stroke cognitive disorders].
    Parfenov VA; Belavina GR; Vakhnina NV; Gusev VV; Levin IaI; Markin SP; Starchina IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):41-5. PubMed ID: 19672226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cognitive dysfunction in elderly patients: diagnosis and treatment].
    Preobrazhenskaia IS; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(11):33-8. PubMed ID: 17176600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent advances in brain metabolic activators].
    Ohtomo E
    No To Shinkei; 1984 Jul; 36(7):619-32. PubMed ID: 6386014
    [No Abstract]   [Full Text] [Related]  

  • 33. [The results of using lucetam in patients with moderate cognitive impairment of different genesis].
    Batysheva TT; Otcheskaia OV; Nesterova ON; Lisinker LN; Bobina LA; Ismailov AM; Shekkhirimov RK; Zhuravleva EIu; Kamchatnov PR; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):63-5. PubMed ID: 19255983
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug therapy of Alzheimer's disease. General concepts on nootropic drugs].
    Otomo E
    Nihon Rinsho; 1988 Jul; 46(7):1569-74. PubMed ID: 3221464
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antihypoxant and antiamnesic effects of calcium ketopantoylaminobutyrate].
    Karavaev AL; Kozlova GS; Smirnova TN; Gunar VI
    Eksp Klin Farmakol; 2005; 68(6):9-11. PubMed ID: 16405026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Akatinol memantine in patients with vascular cognitive disorders].
    Gudkova AA; Sorokina IB; Iakovlev AA; Guliaeva NV; Gekht AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):37-40. PubMed ID: 21311485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Attention-deficit hyperactivity disorder: determination of the optimal medical treatment duration].
    Zavadenko NN; Suvorinova NIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):28-32. PubMed ID: 22500309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nootropic agents in the complex treatment of patients with traumatic epilepsy].
    Lekomtsev VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(6):68-72. PubMed ID: 2171277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of pantogam on visual function and hemodynamic of eyes in patients with primary open-angle glaucoma].
    Davydova NG; Borisova SA; Kolomoĭtseva EM; Abdulkadyrova MZh; Gorshkova IA; Lisitsyna SV
    Vestn Oftalmol; 2002; 118(5):3-5. PubMed ID: 12532734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A strategy for increasing the efficiency of psychopharmacological treatment of hyperkinetic behavior disorder with pantogam].
    Kupriyanova TA; Koren EV; Alabusheva NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11. Vyp. 2):75-79. PubMed ID: 29359723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.